Operator & Board Advisory
The healthcare and biotech sectors operate at a different pace when compared to other industries
The credential
Biotech is a hard and unique entrepreneurship space
Regulatory complexity, capital intensity, decade-long timelines, and a scientific bar that kills most programmes before they reach the clinic. Lymphact navigated all of it — from a university spinout to an EMA/FDA-engaged platform technology programme to a Takeda acquisition. That path is what Tzientzia brings to the table.
ABOUT US
Experienced Management
Biotech boards benefit from an operator who understands the full journey — from early EMA/FDA engagement to a successful exit
Building in biotech means carrying scientific, regulatory, and commercial risk simultaneously. The margin for error is thin and the people who have done it before are rarer than the capital. Tzientzia brings that experience directly into your governance structure
Deep tech Board Advisory
Services
How we work – Helping you with your challenges
Operating Partnership
Board Advisory
Fund Collaboration
Lymphact’s investor and research partners
Connecting an experienced management team
Board-level advisory and operating partnerships for deep-tech founders and the funds backing them. If you’ve been pointed here by someone who knows our work, reach out directly.
